Eli Lilly and Company (LLY) - Yahoo Finance

Find the latest Eli Lilly and Company (LLY) stock quote, history, news and other vital information to help you with your stock trading and investing.

CouponFollow Extension

1%
OFF

Eli Lilly And Company (LLY) Is A Trending Stock: Facts ... - Yahoo …

4 weeks from now

1 day ago · Lilly is expected to post earnings of $5.48 per share for the current quarter, representing a year-over-year change of +120.1%. Over the last 30 days, the Zacks …

yahoo.com

5%
OFF

Why Is Lilly (LLY) Down 5% Since Last Earnings Report? - Yahoo …

4 weeks from now

1 day ago · A month has gone by since the last earnings report for Eli Lilly (LLY). Shares have lost about 5% in that time frame, underperforming the S&P 500. Will the recent negative trend …

yahoo.com

$700
OFF

Eli Lilly And Company (LLY) - Yahoo Finance

4 weeks from now

Eli Lilly (NYSE: LLY) is the most valuable healthcare stock in the world, with a market capitalization of nearly $700 billion. Why is Eli Lilly stock struggling of late? Eli Lilly has been a …

yahoo.com

20%
OFF

Down More Than 20% From Its High, Is Now The Time To Buy Eli …

4 weeks from now

Eli Lilly (NYSE: LLY) is the most valuable healthcare stock in the world, with a market capitalization of nearly $700 billion. But in recent weeks, its share price has been falling. And …

yahoo.com

$700
OFF

Eli Lilly Pops After Biden Proposes Medicare Cover Obesity ... - Yahoo

4 weeks from now

4 days ago · Eli Lilly (NYSE: LLY) is the most valuable healthcare stock in the world, with a market capitalization of nearly $700 billion. ... it dwarfed rivals like Ford Motor Company and …

yahoo.com

$7
OFF

Top Medicare Drugs Headed For Price Cuts | Reuters

4 weeks from now

Aug 15, 2024 · Boehringer Ingelheim and Eli Lilly's , opens new tab Jardiance is used to treat type-2 diabetes, heart failure and chronic kidney disease. It cost Medicare $7 billion for 1.6 …

reuters.com

$52
OFF

HALL Structured Finance Originates A $52.5M Loan Commitment …

4 weeks from now

March 06, 2023 – HALL Structured Finance (HSF) announced today that the company has originated a new first lien construction loan commitment totaling $52.5 million to be used for …

hallgroup.com

FAQs about Eli Lilly and Company (LLY) - Yahoo Finance Coupon?

Why is Eli Lilly (LLY) stock down?

Eli Lilly and Company (LLY) stock is down in Wednesday's premarket trading after the pharmaceutical company reported third quarter results that missed revenue expectations. The disappointing performance was driven by lower-than-anticipated sales of the company's weight loss drug, Zepbound. ...

Is Eli Lilly (LLY) a good stock to buy?

Eli Lilly (LLY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over the past month, shares of this drugmaker have returned -5%, compared to the Zacks S&P 500 composite's +3.1% change. ...

Who is Eli Lilly & Company?

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. ...

Will Eli Lilly top a $1 trillion valuation in the future?

And if you believe, as I do, that the stock may potentially top a $1 trillion valuation in the future, there's good reason to remain bullish on Eli Lilly despite its recent struggles. Eli Lilly (NYSE: LLY) is the most valuable healthcare stock in the world, with a market capitalization of nearly $700 billion. ...

How much did Eli Lilly's new products contribute to revenue?

Eli Lilly’s new products (products launched since 2022 like Ebglyss, Jaypirca, Mounjaro, Kisunla, Omvoh and Zepbound) contributed $4.51 billion to revenues, led by Mounjaro and Zepbound. Sales of Mounjaro and Zepbound disappointed in the third quarter due to inventory issues, per Lilly. ...

Who resigns from Eli Lilly's board of directors?

Eli Lilly and Company (NYSE: LLY) announced today that it has elected Jon Moeller as a new member of its board of directors, effective Dec. 1, 2024. In addition, the company announced that Karen Walker will transition her role with Lilly, resigning as a member of Lilly's board of directors effective Dec. 31, 2024. ...